rsz_annualrepfeat

Annual Reports

Download PDF in English   Annual Report 2015:   View online in English View online in French   Download PDF in English Download PDF in French     

QQ 004

MRC Unit The Gambia Launched 5 year Strategic Plan

The launch of the MRC Unit The Gambia’s 2016-2021 Quinquennial (5-year strategic plan) on the 1 April 2016 was successfully attended by over 400 staff, collaborators and partners. The event offered the opportunity to share our vision, plan for training and highlight recent success stories.

Lab1

MRC Unit The Gambia Launches’ 2016-2021 Quinquennial

The MRC Unit The Gambia (MRCG), is internationally recognised for delivering excellent global health research in Africa and beyond. Building on these achievements, for the next 5 years, MRCG will be launching the 2016-2021 Quinquennial (5 year strategic plan) on the 1 April 2016 at 11am at our main site in Fajara.

(left) Chinelo Ebruke, Phd student, Vaccines and Immunity Team (Right)  Martin Antonio Head, Molecular Microbiology and Mycobacteriology

High genetic diversity of Staphylococcus aureus clones among Gambian villagers

With the global efforts of reducing pneumococcal disease through widespread introduction of pneumococcal vaccines. Concerns have emerged on the potential increase of morbidity and mortality from S. aureus disease in rural Africa, and West Africa in particular where very high rates of carriage of S. pneumoniae have been reported.

20160309_163037_Pregact

Largest ever clinical trial on malaria during pregnancy in Africa

A four-year study (2012-2015), led by the Belgian Institute of Tropical Medicine Antwerp (ITM) and coordinated by Professor Umberto D’Alessandro, shows four available antimalarial treatments are safe to use in pregnancy, providing sound scientific evidence on their use.